FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Alfuzosin Hydrochloride Extended-release Recall

Alfuzosin Hydrochloride Extended-release Tablets, 10 mg, 100-count bottles, Rx only, Di…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
Mar 8, 2017
Recall ID
D-0502-2017
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Alfuzosin Hydrochloride Extended-release starting Jan 5, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0502-2017 on Mar 8, 2017. Reason: Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment.

Product description

Alfuzosin Hydrochloride Extended-release Tablets, 10 mg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, Gujarat, India, NDC 47335-956-88.

Lot numbers, UPCs & expiration codes

Lot #: JKR5219A, JKR5200A, JKR5220A, JKR5221A, JKR5222A, Exp 03/18

Where it was sold

Nationwide in the USA and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0502-2017
Classification
Class II
Status
Terminated
Recall initiated
Jan 5, 2017
FDA report date
Mar 8, 2017
Quantity
22,915 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0502-2017, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
76543
Address
270 Prospect Plains Rd
Code information
Lot #: JKR5219A, JKR5200A, JKR5220A, JKR5221A, JKR5222A, Exp 03/18
Postal code
08512-3605
Report date
Mar 8, 2017
Product type
Drugs
Recall number
D-0502-2017
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
22,915 bottles
Termination date
Jun 29, 2018
Reason for recall
Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Alfuzosin Hydrochloride Extended-release Tablets, 10 mg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, Gujarat, India, NDC 47335-956-88.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Recall initiation date
Jan 5, 2017
Initial firm notification
Letter
Center classification date
Mar 1, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0502-2017, published Mar 8, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls